Yapalı, S. 2021. REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS. AASLD_TASL Digital Hepatology Connect , 2-3.

Yapalı, S., (2021). REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS . AASLD_TASL Digital Hepatology Connect (pp.2-3).

Yapalı, Suna. "REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS," AASLD_TASL Digital Hepatology Connect, 2021

Yapalı, Suna. "REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS." AASLD_TASL Digital Hepatology Connect , pp.2-3, 2021

Yapalı, S. (2021) . "REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS." AASLD_TASL Digital Hepatology Connect , pp.2-3.

@conferencepaper{conferencepaper, author={Suna YAPALI}, title={REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS}, congress name={AASLD_TASL Digital Hepatology Connect}, city={}, country={}, year={2021}, pages={2-3} }